Sign In
Buy LZAGY
$69.59
-1.55 (-2.18%)
At Close: Jul 31, 2026
You Won't Believe the Risk This Healthcare Company Faces
07:30am, Saturday, 21'st Aug 2021
It's older than the dinosaurs.
Lonza Group AG (LZAGY) CEO Pierre-Alain Ruffieux on Q2 2021 Results - Earnings Call Transcript
01:55pm, Friday, 23'rd Jul 2021
Lonza Group AG (LZAGY) CEO Pierre-Alain Ruffieux on Q2 2021 Results - Earnings Call Transcript
12 European Stocks That Analysts Love and Investors Are Ignoring
01:09pm, Tuesday, 25'th May 2021
The stocks could turn out to be winners in coming months if analysts' upbeat calls turn out to be correct.
Lonza Group Ltd (LZAGY) CEO Pierre-Alain Ruffieux on Q4 2020 Results - Earnings Call Transcript
07:30pm, Thursday, 28'th Jan 2021
Lonza Group Ltd (LZAGY) CEO Pierre-Alain Ruffieux on Q4 2020 Results - Earnings Call Transcript
Lonza: Riding The Big Pharma Wave
12:43pm, Sunday, 24'th Jan 2021
Lonza Group is the second deep dive in my CDMO industry series. The company prospered in 2020 and will narrow its focus in 2021.
Lonza shortlists Lanxess, private equity in unit sale, sources say
09:31am, Thursday, 10'th Dec 2020
Swiss contract drug maker Lonza has shortlisted German chemicals group Lanxess and private equity groups in the sale of its Lonza Specialty Ingredients (LSI) unit worth more than 3 billion Swiss franc
7 OTC Stocks That Should Be on Your Radar
10:46am, Friday, 20'th Nov 2020
In a period of high uncertainty, OTC stocks can provide some great money-making opportunities for investors. Here are the top 7 stocks that are worth your time.
